Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00677742
Other study ID # AAAC1723
Secondary ID 1 FPRPA006025010
Status Completed
Phase N/A
First received May 12, 2008
Last updated December 11, 2012
Start date June 2007
Est. completion date November 2012

Study information

Verified date December 2012
Source Columbia University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether getting more packs of birth control pills leads to improved continuation, when compared with getting the traditional supply.


Description:

Discontinuation of oral contraceptive use in the initial months is common; successful early continuation is predictive of long term continuation and prevention of unintended pregnancy. The conventional approach to initiation of hormonal contraceptives in publicly funded clinics across the United States is to give the patient a limited supply of OCs, or a prescription with a limited number of refills, and then have her return to the clinic for a refill. This approach requires the patient to make frequent visits to the clinic, a barrier to method continuation.

This randomized trial will evaluate a simple but potentially powerful change in family planning clinic practice, i.e., the effect of dispensing more versus fewer cycles of oral contraception (OC). The study will be carried out in an urban, publicly funded family planning clinic that serves a population that is poor, young and primarily Hispanic or AfricanAmerican. This population was targeted as its members are at increased risk of discontinuing contraception in the first year of use.


Recruitment information / eligibility

Status Completed
Enrollment 700
Est. completion date November 2012
Est. primary completion date April 2009
Accepts healthy volunteers No
Gender Female
Age group N/A to 35 Years
Eligibility Inclusion Criteria:

- English or Spanish speaker

- age less than or equal to 35 years requesting OC as their primary method of contraception

- currently sexually active or anticipating sexual activity within the next 30 days

Exclusion Criteria:

- contraindications to oral contraceptives per clinic protocol (e.g., hypertension and pregnancy)

- currently using OCs (that is, current users requesting a routine refill)

- desiring pregnancy within the next 6 months

- leaving the clinic catchment area within 6 months

- previous participation in this study

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Other:
enhanced initial supply of oral contraception
7 packs of pills, or 1 pack of pills and a prescription for 6 refills
conventional initial supply of oral contraception
3 packs of pills, or 1 pack of pills and a prescription for 2 refills

Locations

Country Name City State
United States Columbia University Medical Center, Family Planning Clinic New York New York

Sponsors (2)

Lead Sponsor Collaborator
Columbia University Centers for Disease Control and Prevention

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary oral contraception continuation 6 months No
See also
  Status Clinical Trial Phase
Completed NCT04901377 - A Study to Gather Information About User Satisfaction in Women in Russia Who Take Estradiol Valerate/Dienogest